参考文献/References:
[1]van den Bent MJ,Brandes AA,Taphoorn MJ,et al.Adjuvant Procarbazine,Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma:Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951[J].J Clin Oncol,2013,31(3):344-350.
[2]Saha D,Martuza RL,Rabkin SD.Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade[J].Cancer Cell,2017,32(2):253-267.
[3]Longo DL,Boussiotis VA.Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway[J].New England Journal of Medicine,2016,375(18):1767-1778.
[4]Nduom EK,Wei J,Yaghi NK,et al.PD-L1 expression and prognostic impact in glioblastoma[J].Neuro Oncol,2016,18(2):195-205.
[5]Buisseret L,Garaud S,de Wind A,et al.Tumor-infiltrating lymphocyte composition, organization and PD-1/PD-L1 expression are linked in breast cancer[J].Onco Immunology,2017,6(1):e1257452.
[6]De Meulenaere A,Vermassen T,Creytens D,et al.Importance of choice of materials and methods in PD-L1 and TIL assessment in oropharyngeal squamous cell carcinoma[J].Histopathology,2018,73(3):500-509.
[7]Liu J,Zhang S,Hu Y,et al.Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines[J].J Immunother,2016,39(4):171-180.
[8]Dong L,Zheng X,Wang K,et al.PD-1/PD-L1 pathway participates in gastric surgery-induced imbalance of Th17/Treg cells in mice[J].J Trauma Acute Care Surg,2018,85(3):549-559.
[9]Charles NA,Holland EC,Gilbertson R,et al.The brain tumor microenvironment[J].Glia,2012,60(3):502-514.
[10]Platten M,Ochs K,Lemke D,et al.Microenvironmental Clues for Glioma Immunotherapy[J].Curr Neurol Neurosci Rep,2014,14(4):440-371.
[11]Gordon SR,Maute RL,Dulken BW,et al.PD-1 expression by tumor-associated macrophages inhibits phagocytosis and tumor immunity[J].Nature,2017,545(7655):495-499.
[12]Colombo M,Raposo G,Théry C.Biogenesis,Secretion,and Intercellular Interactions of Exosomes and Other Extracellular Vesicles[J].Annu Rev Cell Dev Biol,2014,30(1):255-289.
[13]Chen G,Huang AC,Zhang W,et al.Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response[J].Nature,2018,560(7718):382-386.
[14]Berghoff AS,Kiesel B,Widhalm G,et al.Correlation of immune phenotype with IDH mutation in diffuse glioma[J].Neuro Oncol,2017,19(11):1460-1468.
[15]Wang Y,Wang L.miR-34a attenuates glioma cells progression and chemoresistance via targeting PD-L1[J].Biotechnol Lett,2017,39(10):1485-1492.
[16]Sun NK,Huang SL,Chang PY,et al.Transcriptomic profiling of taxol-resistant ovarian cancer cells identifies FKBP5 and the androgen receptor as critical markers of chemotherapeutic response[J].Oncotarget,2014,5(23):11939-11956.
[17]Romano S,D'Angelillo A,Staibano S,et al.Immunomodulatory pathways regulate expression of a spliced FKBP51 isoform in lymphocytes of melanoma patients[J].Pigment Cell Melanoma Res,2015,28(4):442-452.
[18]D'Arrigo P,Russo M,Rea A,et al.A regulatory role for the co-chaperone FKBP51s in PD-L1 expression in glioma[J].Oncotarget,2017,8(40):68291-68304.
[19]Gong X,Li X,Jiang T,et al.Combined Radiotherapy and Anti-PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non-Small Cell Lung Cancer[J].J Thorac Oncol,2017,12(7):1085-1097.
[20]Song X,Shao Y,Jiang T,et al.Radiotherapy Upregulates Programmed Death Ligand-1 through the Pathways Downstream of Epidermal Growth Factor Receptor in Glioma[J].EBio Medicine,2018,28(1):105-113.
[21]王文超,汪宇,施乐华,等.PD-1/PD-L1信号通路及其在肿瘤免疫治疗中的作用[J].第二军医大学学报,2017,38(9):1190-1195.
[22]中国医师协会脑胶质瘤专业委员会,上海市抗癌协会神经肿瘤分会.中国中枢神经系统胶质瘤免疫和靶向治疗专家共识[J].中华医学杂志,2018,98(5):324.
[23]Lukas RV,Rodon J,Becker K,et al.Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma[J].J Neurooncol,2018,140(2):317-328.
[24]Zhai L,Ladomersky E,Lauing KL,et al.Infiltrating T Cells Increase IDO1 Expression in Glioblastomaand Contribute to Decreased Patient Survival[J].Clin Cancer Res,2017,23(21):6650-6660.
[25]Wainwright DA,Chang AL,Dey M,et al.Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors[J].Clinical Cancer Research,2014,20(20):5290-5301.
[26]Zhai L,Ladomersky E,Dostal CR,et al.Non-tumor cell IDO1 predominantly contributes to enzyme activity and response to CTLA-4/PD-L1 inhibition in mouse glioblastoma[J].Brain Behav Immun,2017,62(1):24-29.
[27]Gorsi HS,Malicki DM,Barsan V,et al.Nivolumab in the Treatment of Recurrent or Refractory Pediatric Brain Tumors: A Single Institutional Experience[J].J Pediatr Hematol Oncol,2018.
相似文献/References:
[1]王国杰,梁日晶,刘 莹,等.3.0T磁共振扩散张量成像与扩散加权成像对单发大脑半球胶质瘤病理分级的诊断价值[J].医学信息,2022,35(09):104.[doi:10.3969/j.issn.1006-1959.2022.09.026]
WANG Guo-jie,LIANG Ri-jing,LIU Ying,et al.Diagnostic Value of 3.0T Magnetic Resonance Diffusion Tensor Imaging and Diffusion Weighted Imaging in Pathological Grading of Single Cerebral Hemispheric Glioma[J].Journal of Medical Information,2022,35(10):104.[doi:10.3969/j.issn.1006-1959.2022.09.026]
[2]蒙新宇.显微镜外科手术治疗脑胶质瘤的近期疗效及对患者认知功能的影响[J].医学信息,2022,35(12):146.[doi:10.3969/j.issn.1006-1959.2022.12.035]
MENG Xin-yu.Effect of Microsurgery on Cognitive Function in Patients with Brain Glioma[J].Journal of Medical Information,2022,35(10):146.[doi:10.3969/j.issn.1006-1959.2022.12.035]
[3]王春城.三维适形放疗在脑胶质瘤治疗中的应用及对生存期的影响[J].医学信息,2019,32(05):173.[doi:10.3969/j.issn.1006-1959.2019.05.057]
WANG Chun-cheng.Application of Three-dimensional Conformal Radiotherapy in the Treatment of Glioma and its Effect on Survival[J].Journal of Medical Information,2019,32(10):173.[doi:10.3969/j.issn.1006-1959.2019.05.057]
[4]黄梦倩,张瑞恒,刘楚浩,等.影像组学在神经系统疾病中的应用研究[J].医学信息,2019,32(16):47.[doi:10.3969/j.issn.1006-1959.2019.16.015]
HUANG Meng-qian,ZHANG Rui-heng,LIU Chu-hao,et al.Application of Radiomics in Nervous System Diseases[J].Journal of Medical Information,2019,32(10):47.[doi:10.3969/j.issn.1006-1959.2019.16.015]
[5]乔秋江,庞 琦.基于自噬相关基因构建的预后模型对脑胶质瘤免疫微环境的影响[J].医学信息,2022,35(17):1.[doi:10.3969/j.issn.1006-1959.2022.17.001]
QIAO Qiu-jiang,PANG Qi.Effect of Prognostic Model Based on Autophagy-related Genes on Immune Microenvironment of Glioma[J].Journal of Medical Information,2022,35(10):1.[doi:10.3969/j.issn.1006-1959.2022.17.001]
[6]许高权.立体定向微创手术治疗脑胶质瘤的临床效果及对患者神经功能和日常生活能力的影响[J].医学信息,2022,35(17):76.[doi:10.3969/j.issn.1006-1959.2022.17.019]
XU Gao-quan.The Clinical Effect of Stereotactic Minimally Invasive Surgery in the Treatment of Patients with Glioma and its Influence on Nerve Function and Daily Living Ability[J].Journal of Medical Information,2022,35(10):76.[doi:10.3969/j.issn.1006-1959.2022.17.019]
[7]许高权.显微外科手术对脑胶质瘤患者认知功能和远期生存率的影响[J].医学信息,2022,35(22):106.[doi:10.3969/j.issn.1006-1959.2022.22.022]
XU Gao-quan.Effect of Microsurgery on Cognitive Function and Long-term Survival Rate in Patients with Glioma[J].Journal of Medical Information,2022,35(10):106.[doi:10.3969/j.issn.1006-1959.2022.22.022]
[8]杨婷婷,占 鸣,谢春梅,等.T2WI灰度直方图定量分析在原发性中枢神经系统淋巴瘤和脑胶质瘤鉴别诊断中的价值[J].医学信息,2021,34(13):4.[doi:10.3969/j.issn.1006-1959.2021.13.002]
YANG Ting-ting,ZHAN Ming,XIE Chun-mei,et al.Quantitative Analysis of T2WI Gray Histogram in the Differential Diagnosis of Primary Central Nervous System Lymphoma and Glioma[J].Journal of Medical Information,2021,34(10):4.[doi:10.3969/j.issn.1006-1959.2021.13.002]
[9]张小芬,陆依娜,徐千惠,等.SWI在脑胶质瘤诊断和治疗中的应用进展[J].医学信息,2023,36(06):181.[doi:10.3969/j.issn.1006-1959.2023.06.041]
ZHANG Xiao-fen,LU Yi-na,XU Qian-hui,et al.Application Progress of SWI in Diagnosis and Treatment of Glioma[J].Journal of Medical Information,2023,36(10):181.[doi:10.3969/j.issn.1006-1959.2023.06.041]